Immediate Impact
41 standout
Citing Papers
From ex vivo to in vivo chimeric antigen T cells manufacturing: new horizons for CAR T-cell based therapy
2025 Standout
Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets
2025 Standout
Works of Mayur Narkhede being referenced
A phase 1 first‐in‐human study of GS‐0189, an anti‐signal regulatory protein alpha (SIRPα) monoclonal antibody, in patients with relapsed/refractory (R/R) non‐Hodgkin lymphoma (NHL)
2023
The association of histologic grade with acute graft‐versus‐host disease response and outcomes
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Mayur Narkhede | 127 | 115 | 106 | 139 | 39 | 301 | |
| H. Gerhartz | 118 | 111 | 72 | 89 | 42 | 348 | |
| Gianna Maria D’Elia | 126 | 87 | 114 | 157 | 32 | 352 | |
| Jacopo Olivieri | 69 | 76 | 76 | 129 | 24 | 359 | |
| Jie Xu | 140 | 185 | 153 | 109 | 46 | 335 | |
| Georgios Paterakis | 92 | 94 | 96 | 87 | 31 | 361 | |
| Sotirios Sachanas | 143 | 206 | 153 | 103 | 31 | 369 | |
| Athina Androulaki | 147 | 143 | 65 | 61 | 29 | 357 | |
| Liya Ma | 90 | 48 | 63 | 111 | 36 | 284 | |
| Mariana Bastos‐Oreiro | 154 | 110 | 62 | 130 | 51 | 326 | |
| Pascale Willem | 167 | 137 | 57 | 83 | 27 | 305 |
All Works
Login with ORCID to disown or claim papers
Loading papers...